Cuyahoga County, Ohio SEC filings desk

Twice an hourEDGAR read 6:10 AM to 10:40 PM Eastern on weekdays, and nightly at 11:55

Cuyahoga Courier Route Pass$1.95 a month, free during preview

Cleveland, Ohio · Nasdaq

ABEO Abeona Therapeutics

Name at EDGAR
ABEONA THERAPEUTICS INC.
Industry
Pharmaceutical preparations
Fiscal year ends
December 31
Filer status
Non-accelerated filer; Smaller reporting company

What it filed, last 12 months

  • Events (8-K)12
  • Periodic reports5
  • Insider forms82
  • Big holders10
  • Proxy and votes3
  • Securities offerings2
  • Other0

Latest filings

  1. ABEO sec.gov
  2. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  3. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  4. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  5. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  6. ABEO sec.gov
  7. ABEO sec.gov
  8. ABEO sec.gov
  9. ABEO sec.gov
  10. ABEO
    8-K Current report

    Abeona Therapeutics 7.01 Regulation FD disclosure

    sec.gov
  11. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  12. ABEO sec.gov
  13. ABEO sec.gov
  14. ABEO
    10-Q Quarterly report

    Abeona Therapeutics period Jun 30, 2026

    sec.gov
  15. ABEO
    8-K Current report

    Abeona Therapeutics 2.02 Results announced

    sec.gov
  16. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  17. ABEO
    424B3 Prospectus

    Abeona Therapeutics

    sec.gov
  18. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  19. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  20. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  21. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  22. ABEO sec.gov
  23. ABEO sec.gov
  24. ABEO sec.gov
  25. ABEO sec.gov
  26. ABEO sec.gov
  27. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  28. ABEO sec.gov
  29. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  30. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  31. ABEO sec.gov
  32. ABEO
    8-K Current report

    Abeona Therapeutics 5.07 Shareholder vote results

    sec.gov
  33. ABEO
    8-K Current report

    Abeona Therapeutics 5.02 Directors or officers

    sec.gov
  34. ABEO
    8-K Current report

    Abeona Therapeutics 7.01 Regulation FD disclosure

    sec.gov
  35. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  36. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  37. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  38. ABEO
    4 Insider transaction report

    Abeona Therapeutics

    sec.gov
  39. ABEO sec.gov
  40. ABEO sec.gov

All 114 filings of the last year →

Insider buys and sells, last 12 months

FiledInsider (as named in the filing)TransactionSharesPriceValue
Vasanthavada MadhavChief Commercial Officer
S Open-market or private sale
4,902 outholds 285,721 after
$5.16
$25,273
O'Malley Brendan M.SVP, Chief Legal Officer
S Open-market or private sale
6,727 outholds 421,226 after
$5.16
$34,682
Vazzano Joseph WalterChief Financial Officer
S Open-market or private sale
9,191 outholds 482,888 after
$5.16
$47,385
Seshadri VishwasDirector, Chief Executive Officer
S Open-market or private sale
19,608 outholds 1,286,500 after
$5.16
$101,091
Alvino MarkDirector
S Open-market or private sale
15,000 outholds 62,065 after
$5.86
$87,966
Vazzano Joseph WalterChief Financial Officer
S Open-market or private sale
1,478 outholds 492,079 after
$6.53
$9,651
Vasanthavada MadhavChief Commercial Officer
S Open-market or private sale
12,606 outholds 290,623 after
$6.96
$87,784
O'Malley Brendan M.SVP, Chief Legal Officer
S Open-market or private sale
12,050 outholds 427,953 after
$6.96
$83,913
Seshadri VishwasDirector, Chief Executive Officer
S Open-market or private sale
67,971 outholds 1,306,108 after
$6.96
$473,330
Vazzano Joseph WalterChief Financial Officer
S Open-market or private sale
24,880 outholds 493,557 after
$6.96
$173,257
Alland LeilaDirector
S Open-market or private sale
11,000 outholds 162,614 after
$5.92
$65,087
Silverstein Christine BerniDirector
S Open-market or private sale
18,160 outholds 119,562 after
$5.71
$103,695